Consider in Biological Technology

Syndication Inc. CEO asks Board of Directors to Consider Routine Quarterly Stock Dividends

'As a Public Company, our most Important Asset is our Shareholders,' says Sorrentino DAMASCUS, Md., Feb. 26 /PRNewswire-FirstCall/ -- Syndication Inc., (Pink Sheets: SYNJ), reports that on February 26th, 2009, the CEO of Syndication asked the BOD to consider declaring quarterly stock dividend...

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

Study of More Than 60,000 Women Underscores Need for Better Understanding of Implications and Risks Associated with Osteoporosis MONTREAL, Sept. 15 /PRNewswire/ -- Results from the Global Longitudinal study of Osteoporosis in Women (GLOW) showed that 55 percent of women diagnosed with o...

To boost advertising results, consider improving your web site

OSHKOSH, Wis. - The secret to building better advertising campaigns may be to build a better web site. According to a recent study from the University of Wisconsin-Oshkosh, consumers use the Internet to investigate and supplement the information they get from traditional advertising. As a resu...

Six things to consider before a major software implementation

Many companies treat the purchase of computer systems like the purchase of a commodity. That can be a big mistake. The software company you are dealing with is not like your other vendors. If you treat the transaction like you're buying supplies, and focus only on price and delivery, you may very...

Location, location, location: Spots to consider for online ads

Recent changes with Google , Yahoo , and MSN have marketers reconsidering the best location for their ads. In recent months, popular search engines have undergone significant changes: Google allows marketers to target specific ad positions within search results; MSN booted all Yahoo ads f...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...isk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements. ThermoGenesis Corp. Web site: http://www.thermogenesis.com ...

ThermoGenesis Provides Update on Fiscal 2009 Results

...isk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements. ThermoGenesis Corp. Web site: http://www.thermogenesis.com ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...easures may assist investors in evaluating the results of the business and analyzing the underlying trends in our business over time. Investors should consider these non-GAAP measures in addition to, not as a substitute for, or as superior to, financial reporting measures prepared in accordance with GAAP. We ...

UCLA welcomes startup to new incubator space at California NanoSystems Institute

... lab space at the CNSI and will move into the incubator space this month, with access to CNSI core lab facilities for research and development. "We consider ourselves very fortunate to have been selected to join the UCLA incubator program at CNSI," said Eric Collins, president and CEO of MediSens. "The col...

Pharmacyclics, Inc. Rights Offering Oversubscribed

...rd-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please...

Micromet Closes $80.5 Million Public Offering of Common Stock

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing

... STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT CAREFULLY WHEN IT IS AVAILABLE, AS IT WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD consider BEFORE MAKING A DECISION ABOUT APPROVING AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES. ...

Micromet Announces Pricing of Public Offering of Common Stock

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...e related GAAP financial measures and the reconciliation of non-GAAP measures to their most closely applicable GAAP measure set forth below and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordan...

Micromet Announces Public Offering of Common Stock

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009

...eriences with prospective patients. It will also provide an opportunity for doctors and medical specialists to not only connect with patients but also consider how stem cell technology can be successfully applied not just overseas, but locally. All patients who are interested, who are considering stem ...

Nanotech particles affect brain development in mice

...e able to demonstrate changes in expression of hundreds of genes. According to Takeda, "Diseases associated with these genes include those we normally consider to develop in childhood, such as autistic disorder, epilepsy and learning disorders, and also others that arise mainly in adulthood or old age, such a...

PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug

...of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors described above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission. ...

Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

...of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors set forth above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission. ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

...The Company uses certain non-GAAP financial measures to supplement its GAAP disclosures. The Company does not, and does not suggest investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, GAAP financial information. These non-GAAP measures may not be consistent...

Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration

...caregivers who are seeking a long-acting medication that provides ADHD symptom improvement from morning through homework and family time may want to consider this Vyvanse study data."( ) On May 22, 2009, the US Food and Drug Administration (FDA) approved a change to the prescribing information for ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

...been excluded from Net income available to common shareholders and Diluted earnings per common share as management of Schering-Plough does not consider these charges to be indicative of continuing operating results. Schering-Plough believes that these "As Reconciled" performance measures cont...

NYU physicists find way to explore microscopic systems through holographic video

...ts to within one billionth of a meter." "That's a tremendous amount of information to obtain about a micrometer-scale object, particularly when you consider that you get all of that information in each snapshot," Grier added. "It exceeds other existing technology in terms of tracking particles and characte...

Pharmacyclics Announces Subscription Price for Rights Offering

...rd-looking statements. Our actual results could differ materially from those projected in the forward-looking statements. Additionally, you should not consider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please...

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results

...r results to be materially different from those expressed or implied in the forward-looking statements. In evaluating these statements, readers should consider various factors, including the risks described in "Item 1A. Risk Factors" beginning on page 15 and elsewhere in the Company's 2009 Annual Report on Fo...

Vasogen Announces Second Quarter 2009 Results

...Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, plans to consider a sale, merger, acquisition, or other alternatives resulting from our strategic review, statements regarding the status of development, or expenditure...

Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009

...wed, is presented in accordance with international accounting standards. We consider the accounting policies to be appropriate to the effect that the Interim Re..., financial position, results of operations and cash flows. Furthermore, we consider the Interim Report to give a true and fair statement of the developments in...

Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing

... STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT CAREFULLY WHEN IT IS AVAILABLE, AS IT WILL CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD consider BEFORE MAKING A DECISION ABOUT APPROVING AN AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES. ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

...of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors set forth above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission. ...

Micromet Added to Russell 3000 Index

...t, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of ...

Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market

...n and CEO Robert J. Coury commented: "Biocon is a first-class, highly respected organization, and I am extremely excited to be able to announce what I consider to be one of the more comprehensive and high quality biologics initiatives reported within the industry to date. After working with our Senior Vice Pr...

Immucor Responds To FDA Notice

...due reliance on any forward-looking statements, and Immucor assumes no obligation to update any forward-looking statements. Immucor urges investors to consider the risks detailed in the Company's filings with the Securities and Exchange Commission. ...

Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)

..."We are delighted to have implemented this agreement because Galichia Heart Hospital offered us the quality of surgical capabilities and facilities we consider essential," said Dr. Arnon Krongrad, chairman and chief executive officer of Mobile Surgery International. "The hospital's location in Wichita will be...

CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering

...L-SCI's financing needs and opportunities are described in more detail in CEL-SCI's most recent annual report on Form 10-K/A and in other SEC filings. consider such risks carefully in considering CEL-SCI's prospects. ...

Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels

... SAO PAULO, June 23 /PRNewswire/ -- What does sugarcane have to do with Global Warming? Everything, when you consider Brazil's highly successful, 30-year experience with sugarcane as a feedstock for ethanol. In place since the mid-70s, the largest program in the world...

Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion

...laim any intention to, and undertake no obligation to, update or revise any forward-looking statements. Readers are also urged to carefully review and consider the other various disclosures in the Company's Annual Report on Form 10-K for the year ended December 31, 2008, as well as other public filings with t...

Top CEOs Declare America's Manufacturing Sector Requires Pro-Industry Policies, Capital Management and Innovation to Maintain Economic Leadership

...le. According to Engler, the federal government needs to consider the long-term impact that increasing costs, adding new regulations, raising...ould be the starting point for the debate in Washington. Policymakers must consider a comprehensive energy policy, a pro-growth tax system, strengthened innova...

Colorado Stem Cell Awareness Rally to Take Place in Denver, Colorado on June 13th, 2009

...eriences with prospective patients. It will also provide an opportunity for doctors and medical specialists to not only connect with patients but also consider how stem cell technology can be successfully implemented in North American medical systems. Complementing their Stem Cell Awareness events, the S...